# EDGAR Filing Document

**Accession Number:** 0000927653
**File Stem:** 0000927653-25-000096
**Filing Date:** 2025-8
**Character Count:** 7622
**Document Hash:** 41740a9a343265b32cefbca7b098794c
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000927653-25-000096.hdr.sgml**: 20250801

**ACCESSION NUMBER**: 0000927653-25-000096

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 14

**CONFORMED PERIOD OF REPORT**: 20250730

**ITEM INFORMATION**: Submission of Matters to a Vote of Security Holders

**FILED AS OF DATE**: 20250801

**DATE AS OF CHANGE**: 20250801

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** MCKESSON CORP
- **CENTRAL INDEX KEY:** 0000927653
- **STANDARD INDUSTRIAL CLASSIFICATION:** WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 943207296
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0331

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-13252
- **FILM NUMBER:** 251174125

**BUSINESS ADDRESS:**
- **STREET 1:** 6555 STATE HIGHWAY 161
- **CITY:** IRVING
- **STATE:** TX
- **ZIP:** 75039
- **BUSINESS PHONE:** 972-446-4800

**MAIL ADDRESS:**
- **STREET 1:** 6555 STATE HIGHWAY 161
- **CITY:** IRVING
- **STATE:** TX
- **ZIP:** 75039

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** MCKESSON HBOC INC
- **DATE OF NAME CHANGE:** 19990115

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** MCKESSON CORP
- **DATE OF NAME CHANGE:** 19950209

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** SP VENTURES INC
- **DATE OF NAME CHANGE:** 19940728

?xml version='1.0' encoding='ASCII'? mck-20250730

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, DC 20549**

**FORM 8-K** 

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d)** 

**of the Securities Exchange Act of 1934**

**Date of report (Date of earliest event reported): July 30, 2025**![mckessonlogoa04.jpg](mck-20250730_g1.jpg)

**McKESSON CORPORATION** 

**(Exact Name of Registrant as Specified in Charter)**

---

| | | |
|:---|:---|:---|
| **Delaware** | **1-13252** | **94-3207296** |
| **(State or Other Jurisdiction<br>of Incorporation)** | **(Commission<br>File Number)** | **(I.R.S. Employer<br>Identification No.)** |

---

**6555 State Hwy 161** 

**Irving, TX 75039** 

**(Address of Principal Executive Offices, and Zip Code)**

**(972) 446-4800** 

**Registrant's Telephone Number, Including Area Code**

**Not Applicable**

**(Former Name or Former Address, if Changed Since Last Report)**

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (*see* General Instruction A.2. below):

☐ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

**Securities registered pursuant to Section 12(b) of the Act:**

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading<br>Symbol(s)** | **Name of each exchange<br>on which registered** |
| Common stock, $0.01 par value | MCK | New York Stock Exchange |
| 1.500% Notes due 2025 | MCK25 | New York Stock Exchange |
| 1.625% Notes due 2026 | MCK26 | New York Stock Exchange |
| 3.125% Notes due 2029 | MCK29 | New York Stock Exchange |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

**Item 5.07 Submission of Matters to a Vote of Security Holders**

On July 30, 2025, McKesson Corporation ("Company") held its Annual Meeting of Shareholders. Shown below are the final vote results on each of the items submitted to a vote and described in the Company's definitive proxy statement filed with the U.S. Securities and Exchange Commission on June 20, 2025.

<u>Item 1</u>. Each of the following individuals nominated by the Board of Directors was elected to serve as a director, having received the following votes:<sup>1</sup>

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Director Nominee** | **Votes For** | **Votes Against** | **Abstentions** | **Broker Non-Votes** |
| Dominic J. Caruso | 99539189 | 881316 | 136711 | 10344141 |
| Lynne M. Doughtie | 100304845 | 118676 | 133695 | 10344141 |
| W. Roy Dunbar | 97858108 | 2559731 | 139377 | 10344141 |
| Deborah Dunsire, M.D. | 100037050 | 386217 | 133949 | 10344141 |
| Julie L. Gerberding, M.D., M.P.H. | 100234521 | 190345 | 132350 | 10344141 |
| James H. Hinton | 99435154 | 982144 | 139918 | 10344141 |
| Donald R. Knauss | 95767822 | 4650316 | 139078 | 10344141 |
| Bradley E. Lerman | 98302502 | 2117813 | 136901 | 10344141 |
| Maria N. Martinez | 94262045 | 6103436 | 191735 | 10344141 |
| Kevin M. Ozan | 100018966 | 400813 | 137437 | 10344141 |
| Brian S. Tyler | 100301689 | 161275 | 94252 | 10344141 |
| Kathleen Wilson-Thompson | 98138663 | 2285359 | 133194 | 10344141 |

---

<u>Item 2</u>. The appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending March 31, 2026 was ratified, having received the following votes:<sup>2</sup>

---

| | | | |
|:---|:---|:---|:---|
| **Votes For** | **Votes Against** | **Abstentions** | **Broker Non-Votes** |
| 102,163,028 | 8,593,072 | 145,257 |  |

---

<u>Item 3</u>. The proposal to approve, on an advisory basis, the compensation of the Company's named executive officers was approved, having received the following votes:<sup>3</sup>

---

| | | | |
|:---|:---|:---|:---|
| **Votes For** | **Votes Against** | **Abstentions** | **Broker Non-Votes** |
| 91,831,997 | 7,955,440 | 769,779 | 10,344,141 |

---

---

| | |
|:---|:---|
| 1 | A nominee will be elected as a director if he or she receives a majority of votes cast (that is, the number of votes cast "for" a director nominee must exceed the number of votes cast "against" that nominee). Abstentions and broker non-votes will not count as votes cast and will have no effect on the outcome of the matter. |
| 2 | Approval requires the affirmative vote of a majority of the voting power of the shares present in person or represented by proxy at the meeting and entitled to vote on the proposal. Shares represented by abstentions will have the effect of a vote against this proposal. Brokers can cast discretionary votes on this proposal. |
| 3 | Approval requires the affirmative vote of a majority of the voting power of the shares present in person or represented by proxy at the meeting and entitled to vote on the proposal. Shares represented by abstentions will have the effect of a vote against this proposal. Broker non-votes with respect to this proposal will have no effect on the outcome of the matter. |

---

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: August 1, 2025

---

| | |
|:---|:---|
| **McKesson Corporation** | **McKesson Corporation** |
| By: | /s/ Michele Lau |
|  | Michele Lau |
|  | Executive Vice President and Chief Legal |
|  | Officer |

---